Table 2.
Characteristicsa of 137 patients receiving bone marrow transplants during treatment for leukemia at 4 study sites between 1985 and 1989.
| Sex | Male | 80 | (58) |
| Female | 57 | (42) | |
| GvHD onset within 5 years | No | 65 | (47) |
| Yes | 72 | (53) | |
| Relapse within 5 years | No | 94 | (69) |
| Yes | 43 | (31) | |
| Return to normal platelet count within 5 years | No | 17 | (12) |
| Yes | 120 | (88) | |
| Leukemia type | ALL | 38 | (28) |
| Low-risk AML | 54 | (39) | |
| High-risk AML | 45 | (33) | |
| CMV status at baseline | Negative | 69 | (50) |
| Positive | 68 | (50) | |
| Vital status 5 years after transplant | Alive or censored | 57 | (42) |
| Dead | 80 | (58) | |
| Age (years); median (IQR) | 28 | (21-35) | |
| Days to transplant; median (IQR) | 6 | (4-8) | |
| Follow up; median (IQR) | 547 | (183-1377) | |
| Days to relapse; median (IQR) | 467 | (122-1363) | |
| Days to normal platelets; median (IQR) | 18 | (14-27) |
a
No. (%), unless otherwise specified
ALL indicates acute lymphocyte leukemia; AML, acute myeloid leukemia; IQR, interquartile range